ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,194Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 1006

$1.13M Total Retail Price of All Prescriptions

Rank: 30 out of 1006

679 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 679 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 679 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 17,467 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 741 722 1 2
LISINOPRIL 624 595 2 3
SIMVASTATIN 553 528 3 1
FUROSEMIDE 538 527 4 6
METOPROLOL TARTRATE 490 475 5 7
AMLODIPINE BESYLATE 472 472 6 4
MIRTAZAPINE 396 376 7 26
OMEPRAZOLE 358 358 8 9
ATORVASTATIN CALCIUM 355 354 9 5
CITALOPRAM HBR 355 321 9 24
ATENOLOL 353 349 11 13
TRAZODONE HCL 309 297 12 21
METOPROLOL SUCCINATE 295 291 13 12
WARFARIN SODIUM 276 262 14 8
DONEPEZIL HCL 253 252 15 17
HYDROCHLOROTHIAZIDE 246 240 16 11
QUETIAPINE FUMARATE 243 243 17 45
ZOLPIDEM TARTRATE 207 204 18 14
NAMENDA 203 203 19 34
GALANTAMINE HBR 198 198 20 233
ESCITALOPRAM OXALATE 193 193 21 27
GABAPENTIN 188 176 22 20
PREDNISONE 179 179 23 33
LOSARTAN POTASSIUM 177 170 24 22
SPIRIVA 174 174 25 48
RISPERIDONE 171 161 26 40
SERTRALINE HCL 164 143 27 19
CLOPIDOGREL 161 161 28 46
ADVAIR DISKUS 161 161 28 37
FLUOXETINE HCL 157 145 30 85
PRAVASTATIN SODIUM 136 135 31 15
DIOVAN 133 133 32 16
CYMBALTA 125 119 33 41
TAMSULOSIN HCL 121 121 34 23
METFORMIN HCL 118 112 35 10
IPRATROPIUM-ALBUTEROL 106 105 36 73
FAMOTIDINE 104 104 37 110
TRAMADOL HCL 103 99 38 35
CARBIDOPA-LEVODOPA 103 103 38 80
METFORMIN HCL ER 102 102 40 56
SEROQUEL 95 95 41 97
RANITIDINE HCL 94 85 42 63
ALENDRONATE SODIUM 94 94 42 29
MELOXICAM 94 94 42 67
LOVASTATIN 94 89 42 44
PLAVIX 92 92 46 61
ALLOPURINOL 91 91 47 31
VESICARE 91 91 47 163
SPIRONOLACTONE 88 88 49 71
ISOSORBIDE MONONITRATE ER 88 88 49 59
OXYCODONE-ACETAMINOPHEN 86 80 S2 51 57
OLANZAPINE 83 83 52 68
OXYBUTYNIN CHLORIDE ER 83 71 52 92
HYDROCODONE-ACETAMINOPHEN 82 81 S3 54 25
POTASSIUM CHLORIDE 81 81 55 30
LEXAPRO 80 80 56 103
PANTOPRAZOLE SODIUM 79 74 57 32
DILTIAZEM 24HR CD 74 74 58 88
LIPITOR 74 74 58 47
NYSTOP 73 73 60 194
DIGOXIN 73 73 60 52
PAROXETINE HCL 71 71 62 62
AZITHROMYCIN 71 71 62 39
QUINAPRIL HCL 70 69 64 86
EVISTA 69 69 65 169
DIVALPROEX SODIUM 68 64 66 53
GLIPIZIDE 67 67 67 69
LIDODERM 67 67 67 66
LANTUS 66 66 69 43
ZETIA 66 65 69 51
METHENAMINE HIPPURATE 64 61 71 279
EXELON 64 64 71 99
TRIAMTERENE-HCTZ 63 55 73 58
FLUTICASONE PROPIONATE 61 59 74 55
VENLAFAXINE HCL ER 59 55 75 105
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 53 76 118
CEPHALEXIN 58 57 76 142
NITROFURANTOIN 58 47 76 205
CILOSTAZOL 56 56 79 269
GLIPIZIDE ER 55 54 80 108
CARVEDILOL 54 54 81 36
FENTANYL 53 53 S2 82 74
JANUVIA 52 52 83 49
LOSARTAN-HYDROCHLOROTHIAZIDE 52 45 83 81
PRADAXA 52 52 83 241
BENAZEPRIL HCL 50 50 86 112
CRESTOR 50 46 86 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 8, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.